Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 2 2Phase NA 1Phase 1 1

Status

Terminated 2Recruiting 2Completed 2Unknown 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Head & Neck 2Genitourinary 2Tumor-Agnostic 1Thoracic 1Endocrine 1Breast 1

Conditions

Thyroid Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Neuroendocrine 1Breast Neoplasms 1Advanced Head and Neck Carcinoma 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2330Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1782Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 935Prednisone 925Cetuximab 921Lenalidomide 916Trastuzumab 901

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × Radiopharmaceuticals × Clear all
NCT07567521 2026-05-29

A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC

C Ray Therapeutics

Phase 1/2 Recruiting
90 enrolled
Genitourinary

Prostatic Neoplasms

NCT06059014 2026-04-24

PRadR

Centre Leon Berard

Phase 1/2 Completed
6 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma

NCT04892303 2025-07-01

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Recruiting
48 enrolled
Head & Neck

Thyroid Neoplasms

NCT02236910 2024-10-15

Lu-DOTA-TATE

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Unknown
66 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT04538950 2023-09-13

PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy

Mayo Clinic

Phase 1/2 Completed
6 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT02325349 2022-07-19

MLAPOCHI

Assistance Publique - Hôpitaux de Paris

Phase 2 Terminated
1 enrolled
Head & NeckThoracic

Advanced Head and Neck Carcinoma

NCT01222416 2017-07-02

PET/CT Evaluation of Treatment Response in Breast Cancer

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
50 enrolled 6 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡